This company has been acquired
Stealth BioTherapeutics Balance Sheet Health
Financial Health criteria checks 0/6
Key information
-30.1%
Debt to equity ratio
US$13.66m
Debt
| Interest coverage ratio | n/a |
| Cash | US$47.14m |
| Equity | -US$45.29m |
| Total liabilities | US$95.52m |
| Total assets | US$50.23m |
Recent financial health updates
Recent updates
Stealth Biotherapeutics chief financial officer Robert Weiskopf leaves company
Sep 30Stealth BioTherapeutics shares pop ~20% premarket after co agrees to go private
Aug 01Stealth BioTherapeutics: A Net-Net Biopharma Going Private
Jul 26Stealth BioTherapeutics receives Nasdaq non-compliance receipt
Jul 11Stealth Biotherapeutics shares soar on EMA orphan drug status for elamipretide
Jun 01Stealth BioTherapeutics skyrockets on data for elamipretide studies
May 06FDA accepts Stealth Bio's Pre-NDA meeting request for elamipretide
Jan 06Reflecting on Stealth BioTherapeutics' (NASDAQ:MITO) Share Price Returns Over The Last Year
Dec 31
Stealth Bio launches $3.2M registered direct offering
Nov 20Financial Position Analysis
Short Term Liabilities: MITO has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: MITO has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: MITO has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: MITO's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if MITO has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if MITO has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.